17-31225125-CT-CTT
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001042492.3(NF1):c.1882dupT(p.Tyr628LeufsTer6) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y628Y) has been classified as Benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001042492.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:4
- -
- -
This sequence change creates a premature translational stop signal (p.Tyr628Leufs*6) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of neurofibromatosis type 1 (PMID: 16835897). This variant is also known as c.1881_1882insT. ClinVar contains an entry for this variant (Variation ID: 457553). For these reasons, this variant has been classified as Pathogenic. -
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2,PP4. -
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 36760809, 16835897) -
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Pathogenic:1
The c.1882dupT pathogenic mutation, located in coding exon 17 of the NF1 gene, results from a duplication of T at nucleotide position 1882, causing a translational frameshift with a predicted alternate stop codon (p.Y628Lfs*6). This alteration has been identified in multiple individuals with a clinical diagnosis of Neurofibromatosis Type 1 (NF1) (Xu W et al. Int J Mol Med, 2014 Jul;34:53-60; Xu M et al. Front Genet, 2018 Jul;9:270). Additionally, this alteration was identified in an individual with cafe au lait macules (Castellanos E et al. Clin Genet, 2020 02;97:264-275). Of note, this alteration is also designated as "c.1877dupT" in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at